HTA64 A Retrospective Review of NICE Appraisals From 2017-2022 to Investigate the Impact of the New Severity Modifier on Cost-Effectiveness Thresholds Across Multiple Therapy Areas
Abstract
Authors
K Christoforou T McLean A Herbert S Alexopoulos